Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2022

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory

Inventory consisted of the following:

	September 30,
(in thousands)	2022
Raw materials	$	5,757
Work-in-progress		54,126
Finished goods		10,924
Total inventory	$	70,807

Schedule Of Other Accrued Liabilities

Other accrued liabilities consisted of the following:

	September 30,		December 31,
(in thousands)	2022		2021
Accrued contract manufacturing expenses	$	5,319	$	—
Accrued clinical expenses		1,062		—
Accrued research expenses		692		—
Accrued professional services		3,542		894
Current portion of lease liabilities		1,170		106
Accrued license fees and royalties		1,155		—
Other		2,180		9
Total other accrued liabilities	$	15,120	$	1,009

Schedule of Other Long-term Liabilities

Other long-term liabilities consisted of the following:

	September 30,
(in thousands)	2022
Long-term portion of lease liabilities	$	2,703
Deferred royalty obligation		75,424
Contingent value rights liability		294
Total other long-term liabilities	$	78,421

There were no other long-term liabilities as of December 31, 2021.